Qiao Li
University Of Michigan Comprehensive Cancer Center, USA
Biography
Qiao Li has been involved in both animal studies and clinical trials in cancer immunotherapy. His laboratory research interests focus on the development of cancer immunotherapy using immune cells, such as T cells, B cells and dendritic cells (DCs). Mechanistically, his novel CSC vaccination strategy conferred host both antibody responses and CTL functions against cancer stem cells which resulted in significantly reduced number of cancer stem cells in the treated host.
Abstract
Abstract : Generation And Application Of Cancer Stem Cell Vaccine In The Adjuvant Setting